USS Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-22,596
Closed -$189K – 599
2022
Q2
$189K Sell
22,596
-4,387
-16% -$61.3K ﹤0.01% 707
2022
Q1
$619K Sell
26,983
-39,775
-60% -$972K 0.01% 701
2021
Q4
$1.85M Hold
66,758
– – 0.01% 640
2021
Q3
$1.87M Buy
66,758
+29,861
+81% +$847K 0.02% 639
2021
Q2
$1.08M Hold
36,897
– – 0.01% 516
2021
Q1
$1.17M Hold
36,897
– – 0.01% 492
2020
Q4
$766K Sell
36,897
-8,300
-18% -$155K 0.01% 524
2020
Q3
$701K Hold
45,197
– – 0.01% 518
2020
Q2
$826K Sell
45,197
-47,620
-51% -$839K 0.01% 493
2020
Q1
$1.44M Buy
92,817
+24,117
+35% +$582K 0.02% 207
2019
Q4
$2.06M Buy
+68,700
New +$1.79M 0.02% 153

Other funds holding BHC

USS Investment Management's BHC Position: Q3 2022 in Review

USS Investment Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 22,596 shares — an estimated $189K sold.

USS Investment Management first reported a position in BHC in Q4 2019 and held it in 11 quarters. The position peaked at $2.06M in Q4 2019. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • USS Investment Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • USS Investment Management sold 22,596 Bausch Health shares in Q3 2022, an estimated $189K.
  • USS Investment Management first reported a position in Bausch Health in Q4 2019 and held it in 11 quarters.
  • USS Investment Management's Bausch Health position peaked at $2.06M in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on USS Investment Management's 13F filing for Q3 2022, filed 8 Nov 2022.